Showing results (1-10 of 54) with videos related to

Sort By:
Pageof 6
World Journal of Gastroenterology|November 4, 2015
Nanomedicine and drug delivery strategies for treatment of inflammatory bowel diseaseHidetoshi Takedatsu, Keiichi Mitsuyama, Takuji Torimura
The Kurume Medical Journal|July 5, 2017
A Rare Case of Ulcerative Colitis with Neurofibromatosis Type 1Shuhei Fukunaga, Hidetoshi Takedatsu, Keiichi Mitsuyama, et al.
Hepatology Research : the Official Journal of the Japan Society of Hepatology|June 17, 2024
Association between nonalcholic fatty liver disease and pancreatic cancer: Epidemiology, mechanisms, and antidiabetic medicationTakahiko Sakaue, Hiroya Terabe, Hidetoshi Takedatsu, et al.
Current Pharmaceutical Design|June 13, 2009
Recent understanding of leukocytapheresis (LCAP) for the treatment of inflammatory bowel diseaseKeiichi Mitsuyama, Hiroshi Yamasaki, Kotaro Kuwaki, et al.
Pediatric Gastroenterology, Hepatology & Nutrition|May 21, 2025
Long-Term Response Durability of Infliximab for Pediatric Inflammatory Bowel Disease in Japan: A Single Center ExperienceNaoya Tsumura, Ken Kato, Ryosuke Yasuda, et al.
Immunity|March 1, 2002
Chronic intestinal inflammatory condition generates IL-10-producing regulatory B cell subset characterized by CD1d upregulationAtsushi Mizoguchi, Emiko Mizoguchi, Hidetoshi Takedatsu, et al.
International Journal of Oncology|January 14, 2004
Detection of a set of peptide vaccine candidates for use in HLA-A31+ epithelial cancer patientsHiroko Takedatsu, Shigeki Shichijo, Kouichi Azuma, et al.
International Journal of Molecular Sciences|January 24, 2020
Topical Therapy with Antisense Tumor Necrosis Factor Alpha Using Novel β-Glucan-Based Drug Delivery System Ameliorates Intestinal InflammationHideto Sakisaka, Hidetoshi Takedatsu, Keiichi Mitsuyama, et al.
Journal of Clinical Medicine|November 14, 2020
Clinical Features and Pathogenic Mechanisms of Gastrointestinal Injury in COVID-19Keiichi Mitsuyama, Kozo Tsuruta, Hidetoshi Takedatsu, et al.
Anticancer Research|November 1, 2007
Therapeutic strategies for targeting the IL-6/STAT3 cytokine signaling pathway in inflammatory bowel diseaseKeiichi Mitsuyama, Satoshi Matsumoto, Junya Masuda, et al.
Pageof 6